LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China
· Delayed Price · Currency is CNY 9.15
+0.24 (2.69%)
At close: Mar 10, 2026
SHE:002644 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 59.08 | 60.07 | 67.19 | 108.65 | 93.26 | 108.02 | Upgrade
|
| Depreciation & Amortization | 51.22 | 51.22 | 52.49 | 49.94 | 48.56 | 45.13 | Upgrade
|
| Other Amortization | 4.65 | 4.65 | 5.98 | 3.65 | 0.38 | 7.62 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | - | -0 | -27.18 | -70.59 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0 | 0.2 | 0.37 | -0.15 | Upgrade
|
| Loss (Gain) From Sale of Investments | 7.23 | 7.23 | 4.49 | 1.3 | 0.85 | 4.05 | Upgrade
|
| Provision & Write-off of Bad Debts | 29.77 | 29.77 | 15.07 | - | - | - | Upgrade
|
| Other Operating Activities | 116.85 | 6.18 | 2.8 | 2.17 | 1.5 | 1.16 | Upgrade
|
| Change in Accounts Receivable | -62.2 | -62.2 | 59.5 | -189.54 | -66.85 | -48.9 | Upgrade
|
| Change in Inventory | 30.26 | 30.26 | -7.3 | -76.02 | -0.8 | 28.94 | Upgrade
|
| Change in Accounts Payable | -79.85 | -79.85 | -134.73 | 163.45 | -49.49 | -17.81 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 23.32 | 11.09 | 3.12 | Upgrade
|
| Operating Cash Flow | 148.67 | 38.98 | 65.71 | 86.61 | 11.85 | 62.89 | Upgrade
|
| Operating Cash Flow Growth | 37.80% | -40.67% | -24.13% | 630.59% | -81.15% | 31.50% | Upgrade
|
| Capital Expenditures | -16.3 | -13.29 | -22.47 | -41.53 | -32.81 | -122.58 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 0.02 | 0 | 0.04 | 41.3 | 93.14 | Upgrade
|
| Cash Acquisitions | - | - | -15.46 | - | - | - | Upgrade
|
| Investment in Securities | 0.34 | 0.34 | 2 | -2.13 | 32.48 | -32.94 | Upgrade
|
| Other Investing Activities | -4.79 | 1.21 | 1.77 | 0.75 | 1.67 | 0.49 | Upgrade
|
| Investing Cash Flow | -20.74 | -11.72 | -34.16 | -42.87 | 42.65 | -61.89 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 19.61 | Upgrade
|
| Long-Term Debt Issued | - | 12 | 25.66 | 2.6 | - | - | Upgrade
|
| Total Debt Issued | 16 | 12 | 25.66 | 2.6 | - | 19.61 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -14.54 | Upgrade
|
| Long-Term Debt Repaid | - | -23.89 | -21.45 | -28.31 | -35.27 | - | Upgrade
|
| Total Debt Repaid | -30.61 | -23.89 | -21.45 | -28.31 | -35.27 | -14.54 | Upgrade
|
| Net Debt Issued (Repaid) | -14.61 | -11.89 | 4.21 | -25.71 | -35.27 | 5.07 | Upgrade
|
| Common Dividends Paid | -7.65 | -15.96 | -27.94 | -7.09 | -61.43 | -30.64 | Upgrade
|
| Other Financing Activities | -1.21 | -1.16 | -1.26 | 3.74 | 3.3 | 2.02 | Upgrade
|
| Financing Cash Flow | -23.48 | -29 | -25 | -29.06 | -93.41 | -23.55 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.31 | 0.31 | 0.67 | 0.7 | -0.21 | -0.08 | Upgrade
|
| Net Cash Flow | 104.76 | -1.43 | 7.23 | 15.38 | -39.11 | -22.62 | Upgrade
|
| Free Cash Flow | 132.37 | 25.7 | 43.24 | 45.08 | -20.95 | -59.69 | Upgrade
|
| Free Cash Flow Growth | 54.18% | -40.58% | -4.08% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 14.78% | 2.62% | 3.72% | 4.32% | -2.56% | -8.94% | Upgrade
|
| Free Cash Flow Per Share | 0.26 | 0.05 | 0.09 | 0.09 | -0.04 | -0.12 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 0.95 | 1.28 | Upgrade
|
| Cash Income Tax Paid | 97.66 | 81.59 | 101.13 | 68.65 | 78.4 | 59.6 | Upgrade
|
| Levered Free Cash Flow | 83.3 | -9.53 | 60.54 | -23.75 | -41.83 | -100.66 | Upgrade
|
| Unlevered Free Cash Flow | 84.27 | -9.02 | 61.32 | -22.91 | -41.24 | -99.86 | Upgrade
|
| Change in Working Capital | -120.1 | -120.1 | -82.3 | -79.31 | -105.88 | -32.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.